Total Payments
$5,582
2023 Payments
$229.94
Companies
22
Transactions
98
Medicare Patients
320
Medicare Billing
$56,723
Payment Breakdown by Category
Food & Beverage$5,575 (99.9%)
Education$5.26 (0.1%)
Travel$2.50 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,575 | 96 | 99.9% |
| Education | $5.26 | 1 | 0.1% |
| Travel and Lodging | $2.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,295 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $794.50 | 12 | $0 (2023) |
| Organogenesis Inc. | $659.49 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $551.86 | 5 | $0 (2023) |
| Esperion Therapeutics, Inc. | $373.78 | 5 | $0 (2022) |
| Novo Nordisk Inc | $313.04 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $310.54 | 9 | $0 (2022) |
| Smith & Nephew, Inc. | $219.11 | 3 | $0 (2018) |
| KCI USA, Inc | $192.34 | 3 | $0 (2019) |
| ITI, Inc. | $132.89 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $229.94 | 2 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2022 | $731.01 | 10 | Janssen Pharmaceuticals, Inc ($232.52) |
| 2021 | $657.61 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($230.72) |
| 2020 | $845.97 | 14 | AstraZeneca Pharmaceuticals LP ($494.86) |
| 2019 | $1,319 | 19 | Janssen Pharmaceuticals, Inc ($609.82) |
| 2018 | $1,352 | 20 | Janssen Pharmaceuticals, Inc ($322.13) |
| 2017 | $447.31 | 15 | Allergan Inc. ($116.57) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $104.94 | General |
| Category: DIABETES | ||||||
| 12/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $96.65 | General |
| Category: DIABETES | ||||||
| 10/26/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $90.35 | General |
| Category: Neuroscience | ||||||
| 09/14/2022 | Organogenesis Inc. | PURAPLY (Medical Supply) | Food and Beverage | Cash or cash equivalent | $124.84 | General |
| Category: Wound Care | ||||||
| 08/25/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 06/23/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2022 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $110.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.55 | General |
| Category: DIABETES | ||||||
| 01/04/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Diabetes Care | ||||||
| 12/22/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $122.90 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: DIABETES | ||||||
| 11/12/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/27/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.65 | General |
| Category: DIABETES | ||||||
| 06/29/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/28/2021 | Misonix Inc | — | Food and Beverage | In-kind items and services | $20.61 | General |
| 05/27/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/18/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/07/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 127 | 261 | $44,009 | $18,657 |
| 2022 | 1 | 22 | 83 | $17,370 | $6,398 |
| 2021 | 2 | 45 | 148 | $23,900 | $10,411 |
| 2020 | 6 | 126 | 354 | $39,197 | $21,257 |
Total Patients
320
Total Services
846
Medicare Billing
$56,723
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 78 | $19,500 | $5,662 | 29.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 85 | $8,415 | $5,177 | 61.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 29 | $6,209 | $2,907 | 46.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 28 | 31 | $4,185 | $2,723 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 38 | $5,700 | $2,188 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 83 | $17,370 | $6,398 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 104 | $19,030 | $8,717 | 45.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 44 | $4,870 | $1,694 | 34.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 111 | $13,320 | $8,379 | 62.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 116 | $11,484 | $6,649 | 57.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 62 | $6,200 | $2,594 | 41.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 17 | $3,638 | $1,846 | 50.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 12 | 13 | $1,755 | $1,090 | 62.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 19 | 35 | $2,800 | $699.38 | 25.0% |
About Dr. Khaled Mahlies, M.D
Dr. Khaled Mahlies, M.D is a Internal Medicine healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497720585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled Mahlies, M.D has received a total of $5,582 in payments from pharmaceutical and medical device companies, with $229.94 received in 2023. These payments were reported across 98 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,575).
As a Medicare-enrolled provider, Mahlies has provided services to 320 Medicare beneficiaries, totaling 846 services with total Medicare billing of $56,723. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bedford, OH
- Active Since 02/22/2006
- Last Updated 07/01/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497720585
Products in Payments
- XARELTO (Drug) $754.01
- JARDIANCE (Drug) $551.86
- LOKELMA (Drug) $363.20
- NEXLIZET (Drug) $349.49
- INVOKANA (Drug) $326.10
- ENTRESTO (Drug) $310.54
- Apligraf (Device) $293.21
- FARXIGA (Drug) $256.66
- Regranex (Drug) $219.11
- SPRAVATO (Drug) $215.35
- Tresiba (Drug) $197.03
- SYMBICORT (Drug) $174.64
- CAPLYTA (Drug) $132.89
- PURAPLY (Medical Supply) $124.84
- Puraply (Medical Supply) $124.01
- Apligraf (Biological) $117.43
- VRAYLAR (Drug) $105.65
- VAC VERAFLO (Device) $101.34
- Xultophy 100/3.6 (Drug) $93.88
- SNAP (Device) $91.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bedford
Dr. Michael Delaughter, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Scott Greenberg, Md, MD
Internal Medicine — Payments: $171,246
Internal Medicine $171,246
Dr. Venkatesan Vidi, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $17,343
Internal Medicine $17,343
Dr. Elmer Smith, Md, MD
Internal Medicine — Payments: $17,311
Internal Medicine $17,311
Paul Kim, Md, MD
Internal Medicine — Payments: $15,775
Internal Medicine $15,775
Alisa Thamwiwat, M.d, M.D
Internal Medicine — Payments: $13,867
Internal Medicine $13,867